TransMed COSI is organizing a Special Interest Group (SIG) during ISMB 2016 in Orlando – July 8, 2016.

In the TransMed SIG meeting, participants will explore the current status of computational biology approaches within the field of translational medicine.

Knowledge-based translational medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, “bench-to-bedside” approach. Large amounts of multi-omics, imaging (medical and molecular) and clinical data can now be captured for given patient populations. In addition to the challenges of data curation and harmonisation, new computational methods are required to identify molecular signatures that suggest disease subtype. These signatures may be predictive of outcome or progression, and impact on disease management by suggesting personalised therapeutic strategies for patients. Such approaches will further the development of a new taxonomy of disease.


Keynote Speakers Confirmed:

Prof. Russ Altman, Professor of Bioengineering, Genetics, Medicine and Computer Science; Director, Biomedical Informatics Training Program, School of Medicine, Stanford University

Prof. Sean Mooney, Professor of Biomedical Informatics and Medical Education, University of Washington; Chief Research Information Officer (CRIO) of UW Medicine

Prof. John Overington, Director of Bioinformatics at Stratified Medical, Visiting Professor at the Institute of Cardiovascular Science, University College London and the Farr Institute


 Key dates:

Abstract submissions deadline: May 27, 2016 

Poster and Presentation acceptance notifications: May 31, 2016

Final program available: June 10, 2016


TransMed 2016 SIG: July 8, 2016


TransMed2016 SIG web site: http://transmedit.org/Main_Page

Registration: https://www.iscb.org/ismb2016-registration

Abstract submission: https://easychair.org/conferences/?conf=transmed2016


Contact: transmed-coord@googlegroups.com


Organizing committee:

Venkata Satagopam, Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg

 
Bissan Al-Lazikani, The Institute of Cancer Research, London, UK
 
Reinhard Schneider, Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg
 
Mansoor Saqi, European Institute for Systems Biology and Medicine, Lyon, France
 
Wei Gu, Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg
 
Irina Balaur, European Institute for Systems Biology and Medicine, Lyon, France